The impact of L-dopa-induced dyskinesias on patients' quality of life in Parkinson's disease: A prospective European study

被引：0
|
作者：
Clarke, CE
Vieregge, P
Ziegler, M
Voinet, C
Pechevis, M
机构：
来源：
NEUROLOGY | 2002年 / 58卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A469 / A469
页数：1
相关论文
共 50 条
  • [1] The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease
    Vidailhet, M
    Bonnet, AM
    Marconi, R
    Durif, F
    Agid, Y
    MOVEMENT DISORDERS, 1999, 14 : 13 - 18
  • [2] Beneficial effects of amantadine on L-Dopa-induced dyskinesias in Parkinson's disease
    Luginger, E
    Wenning, GK
    Bösch, S
    Poewe, W
    MOVEMENT DISORDERS, 2000, 15 (05) : 873 - 878
  • [3] Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease
    Mazzucchi, S.
    Frosini, D.
    Ripoli, A.
    Nicoletti, V.
    Linsalata, G.
    Bonuccelli, U.
    Ceravolo, R.
    ACTA NEUROLOGICA SCANDINAVICA, 2015, 131 (03): : 191 - 195
  • [4] Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease.
    Maurel, F
    Lilliu, H
    Le Pen, C
    REVUE NEUROLOGIQUE, 2001, 157 (05) : 507 - 514
  • [5] Comparison of motor fluctuations and L-dopa-induced dyskinesias in patients with familial and sporadic Parkinson's disease
    Papapetropoulos, S
    Argyriou, AA
    Ellul, J
    Chroni, E
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 (02) : 115 - 119
  • [6] Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease
    Rascol, O
    Arnulf, I
    Paul, HPS
    Brefel-Courbon, C
    Vidailhet, M
    Thalamas, C
    Bonnet, AM
    Descombes, S
    Bejjani, B
    Fabre, N
    Montastruc, JL
    Agid, Y
    MOVEMENT DISORDERS, 2001, 16 (04) : 708 - 713
  • [7] Eltoprazine counteracts l-DOPA-induced dyskinesias in Parkinson's disease: a dose-finding study
    Svenningsson, Per
    Rosenblad, Carl
    Arvidsson, Karolina af Edholm
    Wictorin, Klas
    Keywood, Charlotte
    Shankar, Bavani
    Lowe, David A.
    Bjorklund, Anders
    Widner, Hakan
    BRAIN, 2015, 138 : 963 - 973
  • [8] Serotonergic antidepressant drugs and L-dopa-induced dyskinesias in Parkinson's disease patients: evidence from a retrospective study
    Mazzucchi, S.
    Frosini, D.
    Nicoletti, V.
    Giuntini, M.
    Palermo, G.
    Bonuccelli, U.
    Ceravolo, R.
    JOURNAL OF NEUROLOGY, 2013, 260 : S144 - S144
  • [9] Serotonergic mediated peak-dose L-DOPA-induced dyskinesias in Parkinson's disease
    Politis, M.
    Wu, K.
    Loane, C.
    Kiferle, L.
    Molloy, S.
    Bain, P.
    Brooks, D.
    Piccini, P.
    MOVEMENT DISORDERS, 2012, 27 : S250 - S250
  • [10] L-dopa-induced peak-dose dyskinesias in patients with Parkinson's disease: A clinical pharmacologic approach
    Rascol, O
    MOVEMENT DISORDERS, 1999, 14 : 19 - 32
12345